Rechnung aus WO-Thread...
The registrant had 58,066,483 shares of common stock outstanding as of August 11, 2003.
Date Number of Shares Price Per Share ---- ---------------- ---------------
7/29/03 8,333,333 $0.30 8/14/03 800,000 $0.1506 8/15/03 800,000 $0.1414 8/17/03 1,300,000 $0.145 8/21/03 1,200,000 $0.1502 8/28/03 20,000,000 $0.50 9/01/03 5,181,818 $0.11 9/01/03 50,000 $0.5585
Such shares were purchased in a combination of privately negotiated transactions and open market transactions effected on the Over the Counter Bulletin Board. The shares acquired on September 1, 2003 were the result of conversion to common stock of a convertible debenture dated September 1, 2003.
58,066,483 10Q 11/08/03 + 20,000,000 PP nr.2 28/08/03 + 5,181,818 CD 01/09/03
=83,248,301 O/S(mind.)
********
das KUV kann man ziemlich hoch ansetzen, da die Marge wohl etwa 50% ist...
allgemein bei Biotechs würde ich sagen... KUV ca. 10 bis 20, KGV je nach Gewinndynamik und Marktlage 20 bis 40
|